{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:13:59Z","timestamp":1791465239849,"version":"4.3.4"},"reference-count":111,"publisher":"Portland Press Ltd.","issue":"8","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,4,1]]},"abstract":"<jats:p>Copper is a biometal essential for normal brain development and function, thus copper deficiency or excess results in central nervous system disease. Well-characterized disorders of disrupted copper homoeostasis with neuronal degeneration include Menkes disease and Wilson's disease but a large body of evidence also implicates disrupted copper pathways in other neurodegenerative disorders, including Parkinson's disease, Alzheimer's disease, Amyotrophic lateral sclerosis, Huntington's disease and prion diseases. In this short review we critically evaluate the data regarding changes in systemic and brain copper levels in Parkinson's disease, where alterations in brain copper are associated with regional neuronal cell death and disease pathology. We review copper regulating mechanisms in the human brain and the effects of dysfunction within these systems. We then examine the evidence for a role for copper in pathogenic processes in Parkinson's disease and consider reports of diverse copper-modulating strategies in in\u00a0vitro and in\u00a0vivo models of this disorder. Copper-modulating therapies are currently advancing through clinical trials for Alzheimer's and Huntington's disease and may also hold promise as disease modifying agents in Parkinson's disease.<\/jats:p>","DOI":"10.1042\/cs20150153","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T02:25:45Z","timestamp":1457490345000},"page":"565-574","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics"],"prefix":"10.1042","volume":"130","author":[{"given":"Katherine\u00a0M.","family":"Davies","sequence":"first","affiliation":[{"name":"Neuroscience Research Australia, Sydney, NSW 2031, Australia"},{"name":"School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian\u00a0F.B.","family":"Mercer","sequence":"additional","affiliation":[{"name":"Centre for Cellular and Molecular Biology, School of Life and Environmental Sciences, Deakin University, Melbourne, VIC 3125, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Chen","sequence":"additional","affiliation":[{"name":"Neuroscience Research Australia, Sydney, NSW 2031, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay\u00a0L.","family":"Double","sequence":"additional","affiliation":[{"name":"Brain and Mind Centre and Discipline of Biomedical Sciences, School of Medical Sciences, Sydney Medical School, The University of Sydney, Sydney, NSW 2050, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"key":"2021113010463558800_B1","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.pneurobio.2010.06.001","article-title":"Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions?","volume":"92","author":"Double","year":"2010","journal-title":"Progress Neurobiol."},{"key":"2021113010463558800_B2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cbpa.2008.02.019","article-title":"Metals in Alzheimer's and Parkinson's diseases","volume":"12","author":"Barnham","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"2021113010463558800_B3","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.2174\/092986712800609689","article-title":"Chelating agents for neurodegenerative diseases","volume":"19","author":"Ward","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"2021113010463558800_B4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1179\/1476830511Y.0000000033","article-title":"Cellular and molecular mechanisms of antioxidants in Parkinson's disease","volume":"15","author":"Sutachan","year":"2012","journal-title":"Nutr. Neurosci."},{"key":"2021113010463558800_B5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","article-title":"Wilson's disease and other neurological copper disorders","volume":"14","author":"Bandmann","year":"2015","journal-title":"Lancet Neurol."},{"key":"2021113010463558800_B6","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1021\/acs.biochem.5b00399","article-title":"Fluphenazine.HCl and epigallocatechin gallate modulate the rate of formation and structural properties of apolipoprotein C-II Amyloid Fibrils","volume":"54","author":"Zlatic","year":"2015","journal-title":"Biochemistry"},{"key":"2021113010463558800_B7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1039\/C2MT20151H","article-title":"Localization of copper and copper transporters in the human brain","volume":"5","author":"Davies","year":"2013","journal-title":"Metallomics"},{"key":"2021113010463558800_B8","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","article-title":"Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia","volume":"114","author":"Dexter","year":"1991","journal-title":"Brain"},{"key":"2021113010463558800_B9","doi-asserted-by":"publisher","first-page":"9557","DOI":"10.1021\/ac801817k","article-title":"Intracellular chemical imaging of the developmental phases of human neuromelanin using synchrotron X-ray microspectroscopy","volume":"80","author":"Bohic","year":"2008","journal-title":"Anal. Chem."},{"key":"2021113010463558800_B10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.abb.2008.05.005","article-title":"Cellular multitasking: the dual role of human Cu-ATPases in cofactor delivery and intracellular copper balance","volume":"476","author":"Lutsenko","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"2021113010463558800_B11","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/MCO.0b013e328314b678","article-title":"The risks of free copper in the body and the development of useful anticopper drugs","volume":"11","author":"Brewer","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"2021113010463558800_B12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jnutbio.2003.10.008","article-title":"Functional and molecular responses of suckling rat pups and human intestinal Caco-2 cells to copper treatment","volume":"15","author":"Bauerly","year":"2004","journal-title":"J. Nutr. Biochem."},{"key":"2021113010463558800_B13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jn\/136.1.21","article-title":"Copper transport protein (Ctr1) levels in mice are tissue specific and dependent on copper status","volume":"136","author":"Kuo","year":"2006","journal-title":"J. Nutr."},{"key":"2021113010463558800_B14","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.bbamcr.2012.02.011","article-title":"Charting the travels of copper in eukaryotes from yeast to mammals","volume":"1823","author":"Nevitt","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"2021113010463558800_B15","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1182\/blood-2006-02-003681","article-title":"The Steap proteins are metalloreductases","volume":"108","author":"Ohgami","year":"2006","journal-title":"Blood"},{"key":"2021113010463558800_B16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ng0696-219","article-title":"A murine model of Menkes disease reveals a physiological function of metallothionein","volume":"13","author":"Kelly","year":"1996","journal-title":"Nat. Genet."},{"key":"2021113010463558800_B17","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1093\/hmg\/5.12.1989","article-title":"Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia","volume":"5","author":"Klomp","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"2021113010463558800_B18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng0395-267","article-title":"A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans","volume":"9","author":"Yoshida","year":"1995","journal-title":"Nat. Genet."},{"key":"2021113010463558800_B19","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1073\/pnas.92.7.2539","article-title":"Aceruloplasminemia: molecular characterization of this disorder of iron metabolism","volume":"92","author":"Harris","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010463558800_B20","doi-asserted-by":"publisher","first-page":"23469","DOI":"10.1074\/jbc.272.38.23469","article-title":"The copper chaperone for superoxide dismutase","volume":"272","author":"Culotta","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2021113010463558800_B21","doi-asserted-by":"publisher","first-page":"33191","DOI":"10.1074\/jbc.272.52.33191","article-title":"Purification, characterization, and localization of yeast Cox17p, a mitochondrial copper shuttle","volume":"272","author":"Beers","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2021113010463558800_B22","doi-asserted-by":"publisher","first-page":"36552","DOI":"10.1074\/jbc.M606839200","article-title":"Mitochondrial matrix copper complex used in metallation of cytochrome oxidase and superoxide dismutase","volume":"281","author":"Cobine","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2021113010463558800_B23","doi-asserted-by":"publisher","first-page":"14447","DOI":"10.1074\/jbc.M312693200","article-title":"Yeast contain a non-proteinaceous pool of copper in the mitochondrial matrix","volume":"279","author":"Cobine","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021113010463558800_B24","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1074\/jbc.M311772200","article-title":"Cox17 is functional when tethered to the mitochondrial inner membrane","volume":"279","author":"Maxfield","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021113010463558800_B25","doi-asserted-by":"publisher","first-page":"6842","DOI":"10.1073\/pnas.111058698","article-title":"Essential role for mammalian copper transporter Ctr1\u00a0in copper homeostasis and embryonic development","volume":"98","author":"Lee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010463558800_B26","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.1128\/MCB.22.21.7614-7621.2002","article-title":"Mammalian copper chaperone Cox17p has an essential role in activation of cytochrome C oxidase and embryonic development","volume":"22","author":"Takahashi","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"2021113010463558800_B27","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jmb.2009.04.034","article-title":"Knockdown of human COX17 affects assembly and supramolecular organization of cytochrome c oxidase","volume":"389","author":"Oswald","year":"2009","journal-title":"J. Mol. Biol."},{"key":"2021113010463558800_B28","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/hmg\/ddh197","article-title":"Human SCO1 and SCO2 have independent, cooperative functions in copper delivery to cytochrome c oxidase","volume":"13","author":"Leary","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"2021113010463558800_B29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1046\/j.1471-4159.1999.0720422.x","article-title":"The copper chaperone CCS is abundant in neurons and astrocytes in human and rodent brain","volume":"72","author":"Rothstein","year":"1999","journal-title":"J. Neurochem."},{"key":"2021113010463558800_B30","doi-asserted-by":"publisher","first-page":"G356","DOI":"10.1152\/ajpgi.90632.2008","article-title":"Deletion of hepatic Ctr1 reveals its function in copper acquisition and compensatory mechanisms for copper homeostasis","volume":"296","author":"Kim","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2021113010463558800_B31","doi-asserted-by":"publisher","first-page":"40253","DOI":"10.1074\/jbc.M208002200","article-title":"Characterization of mouse embryonic cells deficient in the ctr1 high affinity copper transporter. Identification of a Ctr1-independent copper transport system","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021113010463558800_B32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1744-8069-6-53","article-title":"Differential expression of ATP7A, ATP7B and CTR1\u00a0in adult rat dorsal root ganglion tissue","volume":"6","author":"Ip","year":"2010","journal-title":"Mol. Pain"},{"key":"2021113010463558800_B33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/ng0193-20","article-title":"Isolation of a partial candidate gene for Menkes disease by positional cloning","volume":"3","author":"Mercer","year":"1993","journal-title":"Nat. Genet."},{"key":"2021113010463558800_B34","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.1016\/S1353-8020(09)70798-9","article-title":"Wilson's disease","volume":"15","author":"Gouider-Khouja","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"2021113010463558800_B35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10534-007-9125-4","article-title":"Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients","volume":"21","author":"Capo","year":"2008","journal-title":"Biometals"},{"key":"2021113010463558800_B36","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/S0021-9258(18)63159-X","article-title":"Studies on the rate of release and turnover of ceruloplasmin and apoceruloplasmin in rat plasma","volume":"245","author":"Holtzman","year":"1970","journal-title":"J. Biol. Chem."},{"key":"2021113010463558800_B37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0300-483X(03)00159-8","article-title":"Copper toxicity, oxidative stress, and antioxidant nutrients","volume":"189","author":"Gaetke","year":"2003","journal-title":"Toxicology"},{"key":"2021113010463558800_B38","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2174\/0929867053764635","article-title":"Metals, toxicity and oxidative stress","volume":"12","author":"Valko","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"2021113010463558800_B39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jns.2013.03.021","article-title":"Brain metal accumulation in Wilson's disease","volume":"329","author":"Litwin","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"2021113010463558800_B40","doi-asserted-by":"publisher","first-page":"e38327","DOI":"10.1371\/journal.pone.0038327","article-title":"Urinary copper elevation in a mouse model of Wilson's disease is a regulated process to specifically decrease the hepatic copper load","volume":"7","author":"Gray","year":"2012","journal-title":"PloS One"},{"key":"2021113010463558800_B41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cmet.2010.04.003","article-title":"Cardiac copper deficiency activates a systemic signaling mechanism that communicates with the copper acquisition and storage organs","volume":"11","author":"Kim","year":"2010","journal-title":"Cell Metab."},{"key":"2021113010463558800_B42","first-page":"1","article-title":"Iron, transferrin, copper and ceruloplasmin of the serum and cerebrospinal fluid in extrapyramidal diseases and primary myopathies. Study in basic conditions and in Parkinsonism after treatment with dopaminergic agents (L-dopa, L-dopa + RO 4\u20134602, amantadine)","volume":"28","author":"Campanella","year":"1973","journal-title":"Acta Neurol."},{"key":"2021113010463558800_B43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/0022-510X(92)90127-7","article-title":"Serum levels of zinc and copper in patients with Parkinson's disease","volume":"112","author":"Jimenez-Jimenez","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"2021113010463558800_B44","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s007020050073","article-title":"Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease","volume":"105","author":"Jimenez-Jimenez","year":"1998","journal-title":"J. Neural. Transm."},{"key":"2021113010463558800_B45","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0140-6736(87)90827-0","article-title":"Raised cerebrospinal-fluid copper concentration in Parkinson's disease","volume":"2","author":"Pall","year":"1987","journal-title":"Lancet"},{"key":"2021113010463558800_B46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1600-0773.1999.tb02015.x","article-title":"Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease","volume":"85","author":"Torsdottir","year":"1999","journal-title":"Pharmacol. Toxicol."},{"key":"2021113010463558800_B47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.brainres.2009.11.085","article-title":"Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives","volume":"1319","author":"Arnal","year":"2010","journal-title":"Brain Res."},{"key":"2021113010463558800_B48","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.neurobiolaging.2012.05.015","article-title":"Fe and Cu do not differ in Parkinson's disease: a replication study plus meta-analysis","volume":"34","author":"Mariani","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"2021113010463558800_B49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF02224396","article-title":"A case control study of CSF copper, iron and manganese in Parkinson disease","volume":"13","author":"Gazzaniga","year":"1992","journal-title":"Ital. J. Neurol. Sci."},{"key":"2021113010463558800_B50","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3143\/geriatrics.31.865","article-title":"Trace elements analysis of serum and cerebrospinal fluid with PIXE\u2013effect of age and changes in parkinsonian patients","volume":"31","author":"Takahashi","year":"1994","journal-title":"Nippon Ronen Igakkai Zasshi"},{"key":"2021113010463558800_B51","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/00002093-199408030-00005","article-title":"Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease","volume":"8","author":"Loeffler","year":"1994","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"2021113010463558800_B52","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.neurobiolaging.2013.09.034","article-title":"Copper pathology in vulnerable brain regions in Parkinson's disease","volume":"35","author":"Davies","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"2021113010463558800_B53","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","article-title":"Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"key":"2021113010463558800_B54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0006-8993(96)00782-2","article-title":"Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders","volume":"738","author":"Loeffler","year":"1996","journal-title":"Brain Res."},{"key":"2021113010463558800_B55","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/ana.23817","article-title":"Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease","volume":"73","author":"Ayton","year":"2013","journal-title":"Ann. Neurol."},{"key":"2021113010463558800_B56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12311-008-0091-3","article-title":"Iron, copper, and zinc distribution of the cerebellum","volume":"8","author":"Popescu","year":"2009","journal-title":"Cerebellum"},{"key":"2021113010463558800_B57","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1017\/S0317167100029140","article-title":"Regional metal concentrations in Parkinson's disease, other chronic neurological diseases, and control brains","volume":"16","author":"Uitti","year":"1989","journal-title":"Can. J. Neurol. Sci."},{"key":"2021113010463558800_B58","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/ana.23817","article-title":"Ceruloplasmin dysfunction and therapeutic potential for parkinson disease","volume":"73","author":"Ayton","year":"2012","journal-title":"Ann. Neurol."},{"key":"2021113010463558800_B59","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.parkreldis.2010.02.007","article-title":"Iron and reactive oxygen species activity in parkinsonian substantia nigra","volume":"16","author":"Wypijewska","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"2021113010463558800_B60","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nbd.2014.12.024","article-title":"Molecular basis of neurodegeneration and neurodevelopmental defects in Menkes disease","volume":"81","author":"Zlatic","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"2021113010463558800_B61","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1021\/ic4031377","article-title":"Site-specific copper-catalyzed oxidation of alpha-synuclein: tightening the link between metal binding and protein oxidative damage in Parkinson's disease","volume":"53","author":"Miotto","year":"2014","journal-title":"Inorg. Chem."},{"key":"2021113010463558800_B62","doi-asserted-by":"publisher","first-page":"10668","DOI":"10.1021\/ic1016752","article-title":"Bioinorganic chemistry of Parkinson's disease: structural determinants for the copper-mediated amyloid formation of alpha-synuclein","volume":"49","author":"Binolfi","year":"2010","journal-title":"Inorg. Chem."},{"key":"2021113010463558800_B63","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1096\/fj.09-130039","article-title":"Unique copper-induced oligomers mediate alpha-synuclein toxicity","volume":"23","author":"Wright","year":"2009","journal-title":"FASEB J."},{"key":"2021113010463558800_B64","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1039\/b926659c","article-title":"Metalloproteomics and metal toxicology of alpha-synuclein","volume":"2","author":"Santner","year":"2010","journal-title":"Metallomics"},{"key":"2021113010463558800_B65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/srep00011","article-title":"Mechanism of copper(II)-induced misfolding of Parkinson's disease protein","volume":"1","author":"Rose","year":"2011","journal-title":"Sci. Rep."},{"key":"2021113010463558800_B66","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1093\/brain\/awh584","article-title":"Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease","volume":"128","author":"Halliday","year":"2005","journal-title":"Brain"},{"key":"2021113010463558800_B67","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1111\/febs.12817","article-title":"Cu(II) and dopamine bind to alpha-synuclein and cause large conformational changes","volume":"281","author":"Tavassoly","year":"2014","journal-title":"FEBS J."},{"key":"2021113010463558800_B68","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/jnr.23323","article-title":"Dopamine and Cu+\/2+ can induce oligomerization of alpha-synuclein in the absence of oxygen: two types\u00a0of oligomerization mechanisms for alpha-synuclein and related cell toxicity studies","volume":"92","author":"Ha","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"2021113010463558800_B69","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1471-4159.2010.06638.x","article-title":"Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity","volume":"113","author":"Wang","year":"2010","journal-title":"J. Neurochem."},{"key":"2021113010463558800_B70","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1126\/science.1252884","article-title":"Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins","volume":"344","author":"Wilhelm","year":"2014","journal-title":"Science"},{"key":"2021113010463558800_B71","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1021\/bi5003025","article-title":"A revised picture of the Cu(II)-alpha-synuclein complex: the role of N-terminal acetylation","volume":"53","author":"Moriarty","year":"2014","journal-title":"Biochemistry"},{"key":"2021113010463558800_B72","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.1021\/jacs.5b01911","article-title":"Copper binding to the N-terminally acetylated, naturally occurring form of alpha-synuclein induces local helical folding","volume":"137","author":"Miotto","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"2021113010463558800_B73","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1039\/c0mt00006j","article-title":"Copper handling machinery of the brain","volume":"2","author":"Lutsenko","year":"2010","journal-title":"Metallomics"},{"key":"2021113010463558800_B74","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/jn\/117.11.1890","article-title":"Milk and casein-based diets for the study of brain catecholamines in copper-deficient rats","volume":"117","author":"Miller","year":"1987","journal-title":"J. Nutr."},{"key":"2021113010463558800_B75","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1471-4159.1975.tb06956.x","article-title":"Copper deficiency in the developing rat brain: evidence for abnormal mitochondria","volume":"25","author":"Prohaska","year":"1975","journal-title":"J. Neurochem."},{"key":"2021113010463558800_B76","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF00691154","article-title":"Neuronal degeneration in the brain of the brindled mouse. II. Ultrastructure of neuronal inclusions in the cerebral cortex","volume":"48","author":"Yajima","year":"1979","journal-title":"Acta Neuropathol."},{"key":"2021113010463558800_B77","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/jn\/112.9.1706","article-title":"Effect of dietary or genetic copper deficiency on brain catecholamines, trace metals and enzymes in mice and rats","volume":"112","author":"Prohaska","year":"1982","journal-title":"J. Nutr."},{"key":"2021113010463558800_B78","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0891-5849(01)00533-0","article-title":"Increased susceptibility of copper-deficient neuroblastoma cells to oxidative stress-mediated apoptosis","volume":"30","author":"Rossi","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"2021113010463558800_B79","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s00018-003-3153-1","article-title":"Prolonged copper depletion induces expression of antioxidants and triggers apoptosis in SH-SY5Y neuroblastoma cells","volume":"60","author":"Lombardo","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"2021113010463558800_B80","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.biochem.72.121801.161647","article-title":"Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis","volume":"74","author":"Valentine","year":"2005","journal-title":"Annu. Rev. Biochem."},{"key":"2021113010463558800_B81","doi-asserted-by":"publisher","first-page":"10887","DOI":"10.1074\/jbc.M113.535112","article-title":"DJ-1 is a copper chaperone acting on SOD1 activation","volume":"289","author":"Girotto","year":"2014","journal-title":"J. Biol. Chem."},{"key":"2021113010463558800_B82","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000337115","article-title":"Copper-zinc superoxide dismutase (SOD1) is released by microglial cells and confers neuroprotection against 6-OHDA neurotoxicity","volume":"21","author":"Polazzi","year":"2013","journal-title":"Neuro-Signals"},{"key":"2021113010463558800_B83","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jns.2005.10.015","article-title":"Ceruloplasmin and superoxide dismutase (SOD1) in Parkinson's disease: a follow-up study","volume":"241","author":"Torsdottir","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"2021113010463558800_B84","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s11064-008-9610-3","article-title":"Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases","volume":"33","author":"Boll","year":"2008","journal-title":"Neurochem. Res."},{"key":"2021113010463558800_B85","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1023\/A:1007680616056","article-title":"Neuroprotective effect of acute and chronic administration of copper (II) sulfate against MPP+ neurotoxicity in mice","volume":"26","author":"Alcaraz-Zubeldia","year":"2001","journal-title":"Neurochem. Res."},{"key":"2021113010463558800_B86","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neuint.2009.01.019","article-title":"Copper reduces striatal protein nitration and tyrosine hydroxylase inactivation induced by MPP+ in rats","volume":"54","author":"Rubio-Osornio","year":"2009","journal-title":"Neurochem. Int."},{"key":"2021113010463558800_B87","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1523\/JNEUROSCI.12-05-01658.1992","article-title":"Transgenic mice with increased Cu\/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity","volume":"12","author":"Przedborski","year":"1992","journal-title":"J. Neurosci."},{"key":"2021113010463558800_B88","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1471-4159.1991.tb03784.x","article-title":"Diethyldithiocarbamate potentiates the neurotoxicity of in\u00a0vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in\u00a0vitro 1-methyl-4-phenylpyridinium","volume":"57","author":"Miller","year":"1991","journal-title":"J. Neurochem."},{"key":"2021113010463558800_B89","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1089\/ars.2006.8.847","article-title":"Posttranslational modifications in Cu,Zn-superoxide dismutase and mutations associated with amyotrophic lateral sclerosis","volume":"8","author":"Furukawa","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"2021113010463558800_B90","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nsb0901-751","article-title":"Heterodimeric structure of superoxide dismutase in complex with its metallochaperone","volume":"8","author":"Lamb","year":"2001","journal-title":"Nat. Struct. Biol."},{"key":"2021113010463558800_B91","doi-asserted-by":"publisher","first-page":"23719","DOI":"10.1074\/jbc.274.34.23719","article-title":"Multiple protein domains contribute to the action of the copper chaperone for superoxide dismutase","volume":"274","author":"Schmidt","year":"1999","journal-title":"J. Biol. Chem."},{"key":"2021113010463558800_B92","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ana.22514","article-title":"DJ-1 modulates the expression of Cu\/Zn-superoxide dismutase-1 through the Erk1\/2-Elk1 pathway in neuroprotection","volume":"70","author":"Wang","year":"2011","journal-title":"Ann. Neurol."},{"key":"2021113010463558800_B93","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/brain\/awh054","article-title":"The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease","volume":"127","author":"Bandopadhyay","year":"2004","journal-title":"Brain"},{"key":"2021113010463558800_B94","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.chembiol.2004.12.003","article-title":"Prana Biotechnology, Limited: metal attenuation in the treatment of neurodegenerative disease","volume":"11","author":"McCarthy","year":"2004","journal-title":"Chem. Biol."},{"key":"2021113010463558800_B95","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5114\/ninp.2013.34397","article-title":"Wilson disease\u2013factors affecting clinical presentation","volume":"47","author":"Litwin","year":"2013","journal-title":"Neurol. Neurochir. Pol."},{"key":"2021113010463558800_B96","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1073\/pnas.98.3.1206","article-title":"Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): an agent for radiotherapy","volume":"98","author":"Lewis","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010463558800_B97","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1084\/jem.20112285","article-title":"The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease","volume":"209","author":"Hung","year":"2012","journal-title":"J. Exp. Med."},{"key":"2021113010463558800_B98","doi-asserted-by":"publisher","first-page":"e90070","DOI":"10.1371\/journal.pone.0090070","article-title":"Neuroprotective copper bis(thiosemicarbazonato) complexes promote neurite elongation","volume":"9","author":"Bica","year":"2014","journal-title":"PLoS One"},{"key":"2021113010463558800_B99","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.nucmedbio.2011.02.016","article-title":"Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET","volume":"38","author":"Ikawa","year":"2011","journal-title":"Nucl. Med. Biol."},{"key":"2021113010463558800_B100","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch. Neurol."},{"key":"2021113010463558800_B101","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nm0409-356","article-title":"The curious case of clioquinol","volume":"15","author":"Cahoon","year":"2009","journal-title":"Nat. Med."},{"key":"2021113010463558800_B102","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy, and biomarker findings of PBT2\u00a0in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurol."},{"key":"2021113010463558800_B103","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-2010-1390","article-title":"PBT2 rapidly improves cognition in Alzheimer's disease: additional phase II analyses","volume":"20","author":"Faux","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"2021113010463558800_B104","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.biocel.2008.01.033","article-title":"Activation of epidermal growth factor receptor by metal-ligand complexes decreases levels of extracellular amyloid beta peptide","volume":"40","author":"Price","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2021113010463558800_B105","doi-asserted-by":"publisher","first-page":"17670","DOI":"10.1074\/jbc.M602487200","article-title":"Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity","volume":"281","author":"White","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2021113010463558800_B106","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1471-4159.2011.07402.x","article-title":"The Alzheimer's therapeutic PBT2 promotes amyloid-beta degradation and GSK3 phosphorylation via a metal chaperone activity","volume":"119","author":"Crouch","year":"2011","journal-title":"J. Neurochem."},{"key":"2021113010463558800_B107","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1474-4422(14)70262-5","article-title":"Safety, tolerability, and efficacy of PBT2\u00a0in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"14","author":"Huntington Study Group Reach2HD Investigators","year":"2015","journal-title":"Lancet Neurol."},{"key":"2021113010463558800_B108","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/978-1-4419-0340-2","article-title":"Clioquinol protects against cell death in Parkinson's disease models in\u00a0vivo and in\u00a0vitro","author":"Wilkins","year":"2009","journal-title":"Basal Ganglia IX"},{"key":"2021113010463558800_B109","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in\u00a0vivo: a novel therapy for Parkinson's disease","volume":"37","author":"Kaur","year":"2003","journal-title":"Neuron"},{"key":"2021113010463558800_B110","first-page":"1020","article-title":"Buddy system for orphan disease","volume":"5","author":"Osherovich","year":"2012","journal-title":"SciBX"},{"key":"2021113010463558800_B111","first-page":"S369","article-title":"PBT434, a novel 8-hydroxyquinazolinone, preserves nigro-striatal circuitry, improves motor performance and inhibits alpha syncuclein accumulation in animal models of Parkinson's disease by modulation of iron homeostasis","volume":"28","author":"Finkelstein","year":"2013","journal-title":"Movement Disorders, Abstract Supplement, Abstracts of the 17th International Congress of Parkinson's Disease and Movement Disorders, Sydney, Australia, 16\u201320 June 2013"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/130\/8\/565\/447266\/cs1300565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/130\/8\/565\/447266\/cs1300565.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:34:30Z","timestamp":1638272070000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/130\/8\/565\/71505\/Copper-dyshomoeostasis-in-Parkinson-s-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,8]]},"references-count":111,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20150153","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,8]]}}}